-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Arena Capital Advisors LLC CA Reduces Stock Position in European Biotech Acquisition Corp. (NASDAQ:EBAC)
Arena Capital Advisors LLC CA Reduces Stock Position in European Biotech Acquisition Corp. (NASDAQ:EBAC)
Arena Capital Advisors LLC CA lowered its holdings in shares of European Biotech Acquisition Corp. (NASDAQ:EBAC – Get Rating) by 94.5% in the 2nd quarter, Holdings Channel.com reports. The firm owned 5,717 shares of the company's stock after selling 98,025 shares during the quarter. Arena Capital Advisors LLC CA's holdings in European Biotech Acquisition were worth $56,000 as of its most recent filing with the Securities & Exchange Commission.
European Biotech Acquisition Price Performance
European Biotech Acquisition stock remained flat at $9.99 during mid-day trading on Friday. 52,698 shares of the company traded hands, compared to its average volume of 30,297. European Biotech Acquisition Corp. has a one year low of $9.66 and a one year high of $10.50. The stock's 50 day moving average is $9.94.
Get European Biotech Acquisition alerts:European Biotech Acquisition Company Profile
(Get Rating)
European Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. European Biotech Acquisition Corp. was incorporated in 2021 and is based in Amsterdam, the Netherlands.Read More
- Get a free copy of the StockNews.com research report on European Biotech Acquisition (EBAC)
- Oil Is a Compelling Reason The Sell-Off In Stocks Isn't Over
- Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
- Six Flags is a Ride You Don't Want to Get Stuck On
- Hanesbrands May be Signaling a Bad Week for Retail Stocks
- Vision Hydrogen, Now Vision Energy, Puts Hopes In Stock Split
Want to see what other hedge funds are holding EBAC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for European Biotech Acquisition Corp. (NASDAQ:EBAC – Get Rating).
Receive News & Ratings for European Biotech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for European Biotech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
Arena Capital Advisors LLC CA lowered its holdings in shares of European Biotech Acquisition Corp. (NASDAQ:EBAC – Get Rating) by 94.5% in the 2nd quarter, Holdings Channel.com reports. The firm owned 5,717 shares of the company's stock after selling 98,025 shares during the quarter. Arena Capital Advisors LLC CA's holdings in European Biotech Acquisition were worth $56,000 as of its most recent filing with the Securities & Exchange Commission.
競技場資本顧問有限責任公司 CA 降低了歐洲生物技術收購公司股份持有 (納斯達克:EBAC-獲得評級) 94.5% 在第二季度, 控股 Channel.com 報告.該公司在本季度賣出 98,025 股股票後擁有該公司股票的 5,717 股股份。競技場資本顧問有限責任公司 CA 在歐洲生物技術收購中的持有價值 56,000 美元,因為其最近向證券交易委員會提交的文件。
European Biotech Acquisition Price Performance
歐洲生技收購價格表現
European Biotech Acquisition stock remained flat at $9.99 during mid-day trading on Friday. 52,698 shares of the company traded hands, compared to its average volume of 30,297. European Biotech Acquisition Corp. has a one year low of $9.66 and a one year high of $10.50. The stock's 50 day moving average is $9.94.
歐洲生物技術收購股在周五中間交易期間保持平穩 9.99 美元。該公司的 52,698 股交易手,相比其平均交易量為 30,297。歐洲生物技術收購公司擁有一年低點 9.66 美元,一年新高為 10.50 美元。該股票的 50 日移動平均線為 9.94 美元。
European Biotech Acquisition Company Profile
歐洲生物科技收購公司簡
(Get Rating)
(取得評分)
Read More
閱讀更多
- Get a free copy of the StockNews.com research report on European Biotech Acquisition (EBAC)
- Oil Is a Compelling Reason The Sell-Off In Stocks Isn't Over
- Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
- Six Flags is a Ride You Don't Want to Get Stuck On
- Hanesbrands May be Signaling a Bad Week for Retail Stocks
- Vision Hydrogen, Now Vision Energy, Puts Hopes In Stock Split
- 獲取有關歐洲生物技術收購研究報告的免費副本
- 石油是一個令人信服的原因,股票的拋售還沒有結束
- 井噴 Q3 報告後,中型腦神經分泌生物科學是否購買?
- 六旗是你不想陷入困境的旅程
- Hanes品牌可能信號零售股票周
- 視覺氫氣,現在視覺能源,把希望放在股票分裂
Want to see what other hedge funds are holding EBAC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for European Biotech Acquisition Corp. (NASDAQ:EBAC – Get Rating).
想看看還有哪些對沖基金持有 EBAC? 訪問 Holdingschannel.com 以獲取歐洲生物技術收購公司(納斯達克:EBAC-獲得評級)的最新 13 樓文件和內幕交易。
Receive News & Ratings for European Biotech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for European Biotech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
接收歐洲生物技術收購日報的新聞和評分 -在下面輸入您的電子郵件地址,以通過 MarketBeat.com 的免費每日電子郵件通訊接收歐洲生物技術收購及相關公司的最新新聞和分析師評級的簡要每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧